These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Rubenstein JH; Inadomi JM; Scheiman J; Schoenfeld P; Appelman H; Zhang M; Metko V; Kao JY Clin Gastroenterol Hepatol; 2014 Feb; 12(2):239-45. PubMed ID: 23988686 [TBL] [Abstract][Full Text] [Related]
3. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population. Peng S; Cui Y; Xiao YL; Xiong LS; Hu PJ; Li CJ; Chen MH Endoscopy; 2009 Dec; 41(12):1011-7. PubMed ID: 19967617 [TBL] [Abstract][Full Text] [Related]
5. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review. Yadlapati R; Gyawali CP; Pandolfino JE; Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084 [TBL] [Abstract][Full Text] [Related]
6. Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus. Rubenstein JH; Morgenstern H; McConell D; Scheiman JM; Schoenfeld P; Appelman H; McMahon LF; Kao JY; Metko V; Zhang M; Inadomi JM Gastroenterology; 2013 Dec; 145(6):1237-44.e1-5. PubMed ID: 23999171 [TBL] [Abstract][Full Text] [Related]
7. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited. Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425 [TBL] [Abstract][Full Text] [Related]
8. Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy. Soricelli E; Casella G; Baglio G; Maselli R; Ernesti I; Genco A Surg Obes Relat Dis; 2018 Jun; 14(6):751-756. PubMed ID: 29571635 [TBL] [Abstract][Full Text] [Related]
10. Erosive Esophagitis Portends a Benign Clinical Course in the Majority of Patients. Bi D; Katzka DA; Lavey CJ; Geno DM; Ravi K Dig Dis Sci; 2020 Nov; 65(11):3244-3252. PubMed ID: 31907769 [TBL] [Abstract][Full Text] [Related]
11. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL. DE Carli DM; Araujo AF; Fagundes RB Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045 [TBL] [Abstract][Full Text] [Related]
12. Nighttime heartburn in patients with gastroesophageal reflux disease under routine care. Nocon M; Labenz J; Jaspersen D; Leodolter A; Meyer-Sabellek W; Stolte M; Vieth M; Lind T; Malfertheiner P; Willich SN Digestion; 2008; 77(2):69-72. PubMed ID: 18349541 [TBL] [Abstract][Full Text] [Related]
13. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD]. Endzinas Z; Mickevicius A; Kiudelis M Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039 [TBL] [Abstract][Full Text] [Related]
14. The potential impact of contemporary developments in the management of patients with gastroesophageal reflux disease undergoing an initial gastroscopy. Salem SB; Kushner Y; Marcus V; Mayrand S; Fallone CA; Barkun AN Can J Gastroenterol; 2009 Feb; 23(2):99-104. PubMed ID: 19214284 [TBL] [Abstract][Full Text] [Related]
15. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Voutilainen M; Sipponen P; Mecklin JP; Juhola M; Färkkilä M Digestion; 2000; 61(1):6-13. PubMed ID: 10671769 [TBL] [Abstract][Full Text] [Related]
16. Erosive esophagitis and Barrett's esophagus in Taiwan: a higher frequency than expected. Yeh C; Hsu CT; Ho AS; Sampliner RE; Fass R Dig Dis Sci; 1997 Apr; 42(4):702-6. PubMed ID: 9125635 [TBL] [Abstract][Full Text] [Related]
17. Erosive esophagitis is a risk factor for Barrett's esophagus: a community-based endoscopic follow-up study. Ronkainen J; Talley NJ; Storskrubb T; Johansson SE; Lind T; Vieth M; Agréus L; Aro P Am J Gastroenterol; 2011 Nov; 106(11):1946-52. PubMed ID: 21946284 [TBL] [Abstract][Full Text] [Related]
18. Significant decline in the prevalence of Barrett's esophagus among patients with gastroesophageal reflux disease. Hamade N; Weng G; Desai M; Chandrasekar VT; Dasari C; Kennedy K; Sharma P Dis Esophagus; 2021 May; 34(5):. PubMed ID: 33458760 [TBL] [Abstract][Full Text] [Related]
19. Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication. Stein HJ; Kauer WK; Feussner H; Siewert JR J Gastrointest Surg; 1998; 2(4):333-41. PubMed ID: 9841990 [TBL] [Abstract][Full Text] [Related]
20. Laparoscopic treatment of obese patients with gastroesophageal reflux disease and Barrett's esophagus: a prospective study. Braghetto I; Korn O; Csendes A; Gutiérrez L; Valladares H; Chacon M Obes Surg; 2012 May; 22(5):764-72. PubMed ID: 22392129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]